Quick Read
POET (NASDAQ: POET) fell 27% in a week, but our BUY-rated price target of $22.49 implies roughly 100% upside from current levels.
A $50M Lumilens purchase order, scalable to $500M over five years, anchors POET’s bull case alongside a planned 800G production ramp starting Q3 2026.
Even the bear case targets $16.79, which would represent a 49% gain, suggesting POET’s sharp weekly selloff already priced in its $291M accumulated deficit and execution risks.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Poet Technologies didn’t make the cut. Grab the names FREE today.
Our POET Technologies (NASDAQ:POET) call is straightforward: the stock could nearly double from here over the next 12 months. With shares trading at $11.25 after a sharp pullback, our 24/7 Wall St. price target for POET is $22.49, implying 99.91% upside.
24/7 WallSt
We rate POET a buy with 50% model confidence, a moderate conviction level that reflects strong commercial catalysts balanced against pre-revenue execution risk.
24/7 Wall St. Price Target Summary
Metric
Value
Current Price
$11.25
24/7 Wall St. Price Target
$22.49
Upside
99.91%
Recommendation
BUY
Confidence Level
50%
A Whiplash Quarter for POET Shareholders
POET has been one of 2026’s wildest rides. Shares are up 77.73% year to date and 170.43% over the past year, but the last week tells a different story. The stock fell 27.3% in seven days and 18.06% over the past month, leaving POET 16% off its 52-week high of $20.81.
The pullback followed a Q1 2026 earnings report that was a tale of two halves. Revenue of $503,389 beat consensus by 44.66% and grew 201.9% year over year, but EPS of -$0.08 missed the -$0.04 estimate. The headline catalyst was a Lumilens joint development agreement carrying an initial $50 million purchase order that POET says could scale beyond $500 million over five years.
The Case for $23 and Beyond
The bull case is a production ramp story. Management guided to ship more than 30,000 optical…
..
